Differential recognition of liganded and unliganded thyroid hormone receptor by retinoid X receptor regulates transcriptional repression

Molecular and Cellular Biology

Volumn 17, Issue 12, 1997, Pages 6887-6897

  Zhang, Jinsong ^a   Zamir, Iris ^a   Lazar, Mitchell A ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOID; RETINOID X RECEPTOR; THYROID HORMONE; THYROID HORMONE RECEPTOR;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; DIMERIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; RAT; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0030666624     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.17.12.6887     Document Type: Article

References (47)

1. Au-Fliegner, M., E. Helmer, J. Casanova, B. M. Raaka, and H. H. Samuels. 1993. The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation. Mol. Cell. Biol. 13:5725-5737.
2. Baniahmad, A., A. C. Kohne, and R. Renkawitz. 1992. A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor. EMBO J. 11:1015-1023.
3. Baniahmad, A., X. Leng, T. P. Burris, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley. 1995. The τ4 activation domain of the thyroid hormone receptor is required for release of a putative corepressor(s) necessary for transcriptional silencing. Mol. Cell. Biol. 15:76-86.
4. Barettino, D., T. H. Bugge, P. Bartunek, M. D. M. Vivanco-Ruiz, V. Sonntag-Buck, H. Beug, M. Zenke, and H. G. Stunnenberg. 1993. Unliganded T3R, but not its oncogenic variant, v-erbA, suppresses RAR-dependent transactivation by titrating out RXR. EMBO J. 12:1343-1354.
5. Bourguet, W., M. Ruff, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature 375:377-382.
6. Bugge, T. H., J. Pohl, O. Lonnoy, and H. G. Stunnenberg. 1992. RXRα, a promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO J. 11:1409-1418.
7. Carey, M., H. Kakidani, J. Leatherwood, F. Mostashari, and M. Ptashne. 1989. An amino terminal fragment of GAL4 binds DNA as a dimer. J. Mol. Biol. 209:423-432.
8. Casanova, J., E. Helmer, S. Selmi-Ruby, J. S. Qi, M. Au-Fliegner, V. Desai-Yajnik, N. Koudinova, F. Yarm, B. M. Raaka, and H. H. Samuels. 1994. Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor. Mol. Cell. Biol. 14:5756-5765.
9. Chen, H. W., and M. L. Privalsky. 1993. The erbA oncogene represses the actions of both retinoid X and retinoid A receptors but does so by distinct mechanisms. Mol. Cell. Biol. 13:5970-5980.
10. Chen, J. D., and R. M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457.
11. Collingwood, T. N., A. Butler, Y. Tone, R. J. Clifton-Bligh, M. G. Parker, and V. K. Chatterjee. 1997. Thyroid hormone-mediated enhancement of heterodimer formation between thyroid hormone receptor β and retinoid X receptor. J. Biol. Chem. 272:13060-13065.
12. Collingwood, T. N., O. Rajanayagam, M. Adams, R. Wagner, V. Cavailles, E. Kalkhoven, C. Matthews, E. Nystrom, K. Stenlof, G. Lindstedt, L. Tisell, R. J. Fletterick, M. G. Parker, and V. K. K. Chatterjee. 1997. A natural transactivation mutation in the thyroid hormone β receptor: impaired interaction with putative transcriptional mediators. Proc. Natl. Acad. Sci. USA 94:248-253.
13. Damm, K., R. A. Heyman, K. Umesono, and R. M. Evans. 1993. Functional inhibition of retinoic acid response by dominant negative retinoic acid receptor mutants. Proc. Natl. Acad. Sci. USA 90:2989-2993.
14. Forman, B. M., K. Umesono, J. Chen, and R. M. Evans. 1995. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell 81:541-550.
15. Harding, H. P., and M. A. Lazar. 1995. The monomer-binding orphan receptor Rev-Erb represses transcription as a dimer on a novel direct repeat. Mol. Cell. Biol. 15:4791-4802.
16. Hasumura, S., S. Kitagawa, I. Pastan, and S. Y. Cheng. 1985. Solubilization and characterization of a membrane 3,3′,5-triiodothyronine binding protein from rat pituitary GH3 cells. Biochem. Biophys. Res. Commun. 133:837-843.
17. Horlein, A. J., A. M. Naar, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Soderstrom, C. K. Glass, and M. G. Rosenfeld. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404.
18. Katz, D., and M. A. Lazar. 1993. Dominant negative activity of an endogenous thyroid hormone receptor variant (α2) is due to competition for binding sites on target genes. J. Biol. Chem. 268:20904-20910.
19. Kliewer, S. A., K. Umesono, D. J. Mangelsdorf, and R. M. Evans. 1992. Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone, and vitamin D3 signalling. Nature 355:446-449.
20. Kurokawa, R., M. Soderstrom, A. Horlein, S. Halachmi, M. Brown, M. G. Rosenfeld, and C. K. Glass. 1995. Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377:451-454.
21. Kurokawa, R., V. C. Yu, A. Naar, S. Kyakumoto, Z. Han, S. Silverman, M. G. Rosenfeld, and C. K. Glass. 1993. Differential orientations of the DNA-binding domain and carboxy-terminal dimerization interface regulate binding site selection by nuclear receptor heterodimers. Genes Dev. 7:1423-1435.
22. Lazar, M. A., T. J. Berrodin, and H. P. Harding. 1991. Differential DNA binding by monomeric, homodimeric, and potentially heteromeric forms of the thyroid hormone receptor. Mol. Cell. Biol. 11:5005-5015.
23. Leid, M., P. Kastner, R. Lyons, H. Nakshatri, M. Saunders, T. Zacharewski, J.-Y. Chen, A. Staub, J.-M. Garnier, S. Mader, and P. Chambon. 1992. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell 68: 377-395.
24. Mangelsdorf, D. J., E. S. Ong, J. A. Dyck, and R. M. Evans. 1990. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 345: 224-229.
25. Marks, M. S., P. L. Hallenback, T. Nagata, J. H. Segars, E. Appella, V. M. Nikodem, and K. Ozato. 1992. H-2RIIBP (RXRβ) dimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. EMBO J. 11:1419-1435.
26. Martin, B., R. Renkawitz, and M. Muller. 1994. Two silencing subdomains of v-erbA synergize with each other, but not with RXR. Nucleic Acids Res. 22:4899-4905.
27. McDonnell, D. P., S. L. Dana, P. A. H. Pa, B. A. Lieberman, M. O. Imhof, and R. B. Stein. 1995. Cellular mechanisms which distinguish between hormone-and antihormone-activated estrogen receptor. Ann. N. Y. Acad. Sci. 761:121-137.
28. Nagaya, T., and J. L. Jameson. 1993. Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance. J. Biol. Chem. 268:15766-15771.
29. Perlmann, T., P. N. Rangarajan, K. Umesono, and R. M. Evans. 1993. Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev. 7:1411-1422.
30. Rastinejad, F., T. Perlmann, R. M. Evans, and P. B. Sigler. 1995. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature 375:203-211.
31. Reginato, M. J., J. Zhang, and M. A. Lazar. 1996. DNA-independent and DNA-dependent mechanisms regulate the differential heterodimerization of the isoforms of the thyroid hormone receptor with retinoid X receptor. J. Biol. Chem. 271:28199-28205.
32. Renaud, J.-P., N. Rochel, M. Ruff, V. Vivat, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal structure of the RARγ ligand-binding domain bound to all-trans retinoic acid. Nature 378:681-689.
33. Rentoumis, A., V. K. K. Chatterjee, L. D. Madison, S. Datta, G. D. Gallagher, L. J. deGroot, and J. L. Jameson. 1990. Negative and positive transcriptional regulation by thyroid hormone receptor isoforms. Mol. Endocrinol. 4:1522-1531.
34. Sande, S., and M. L. Privalsky. 1996. Identification of TRACs, a family of co-factors that associate with and modulate the activity of nuclear hormone receptors. Mol. Endocrinol. 10:813-825.
35. Schulman, I. G., H. Juguilon, and R. M. Evans. 1996. Activation and repression bv nuclear hormone receptors: hormone modulates an equilibrium between active and repressive states. Mol. Cell. Biol. 16:3807-3813.
36. Schulman, I. G., C. Li, J. W. R. Schwabe, and R. M. Evans. 1997. The phantom ligand effect: allosteric control of transcription by the retinoid X receptor. Genes Dev. 11:299-308.
37. Seol, W., M. J. Mahon, Y.-K. Lee, and D. D. Moore. 1996. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR. Mol. Endocrinol. 10:1646-1655.
38. Tone, Y., T. N. Collingwood, M. Adams, and V. K. Chatterjee. 1994. Functional analysis of a transactivation domain in the thyroid hormone beta receptor. J. Biol. Chem. 269:31157-31161.
39. Umesono, K., K. K. Murakami, C. C. Thompson, and R. M. Evans. 1991. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65:1255-1266.
40. Wagner, R. L., J. W. Apriletti, M. E. McGrath, B. L. West, J. D. Baxter, and R. J. Fletterick. 1995. A structural role for hormone in the thyroid hormone receptor. Nature 378:690-697.
41. Willy, P. J., and D. J. Mangelsdorf. 1997. Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR. Genes Dev. 11:289-298.
42. Yang, Y.-Z., M. Burgos-Trinadad, Y. Wu, and R. J. Koenig. 1996. Thyroid hormone receptor variant a2. Role of the ninth heptad in DNA binding, heterodimerization with retinoid X receptor, and dominant negative activity. J. Biol. Chem. 271:28235-28242.
43. Yoh, S. M., V. K. K. Chatterjee, and M. L. Privalsky. 1997. Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. Mol. Endocrinol. 11:470-480.
44. Yu, V. C., C. Delsert, B. Anderson, J. M. Holloway, O. V. Devary, A. M. Naar, S. Y. Kim, J.-M. Boutin, C. K. Glass, and M. G. Rosenfeld. 1991. RXRβ: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67:1251-1266.
45. Zamir, I., H. P. Harding, G. B. Atkins, A. Horlein, C. K. Glass, M. G. Rosenfeld, and M. A. Lazar. 1996. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with different repression domains. Mol. Cell. Biol. 16:5458-5465.
46. Zamir, I., J. Zhang, and M. A. Lazar. 1997. Stoichiometric and steric principles governing repression by nuclear hormone receptors. Genes Dev. 11: 835-846.
47. Zhang, X.-K., B. Hoffmann, P. B.-V. Tran, G. Graupner, and M. Pfahl. 1992. Retinoid X receptor is an auxilliary protein for thyroid and retinoic acid receptors. Nature 355:441-446.